Mass Spectrometry Market: A Visionary Outlook for Business Leaders
The global mass spectrometry market, valued at US$5.82 million in 2023, stood at US$6.33 million in 2024 and is projected to advance at a resilient CAGR of 7.2% from 2024 to 2030, culminating in a forecasted valuation of US$9.62 million by the end of the period.
In the evolving landscape of life sciences, pharmaceuticals, environmental monitoring, and clinical diagnostics, mass spectrometry...
How Is Live Cell Imaging Revolutionizing Drug Discovery and Personalized Medicine?
As the biotechnology and pharmaceutical sectors race to accelerate innovation, live cell imaging has emerged as a vital enabler in transforming how we understand disease, evaluate therapies, and personalize treatment. But what is driving this market forward, and why should C-level executives and senior decision-makers pay close attention?
The global live cell imaging market, valued at US$3.13 billion...
Why Is the Global Demand for Empty Medicine Capsules Accelerating in Pharma and Nutraceuticals?
As healthcare becomes increasingly personalized and wellness-driven, empty medicine capsules are playing a critical role in transforming how drugs and supplements are formulated and delivered. Valued at USD 3.0 billion in 2023, the global empty capsules market is projected to hit USD 4.2 billion by 2029, growing at a CAGR of 6.3%. This growth is powered by technological...
The Rise of Exosome Technologies: A Strategic Overview for Healthcare Stakeholders
The Exosome Diagnostics and Therapeutics Market The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, is forecasted to grow at a robust CAGR of 81.2%, reaching US$59 million in 2024 and an impressive US$6848 million by 2032.
However, the candidates for exosome-based therapeutics are expected to be launched in the market from 2029 onwards. Thus, exosome...
Biomaterials Market Insights: From Regenerative Medicine to Medical Devices
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market...
Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032
The Exosome Diagnostics and Therapeutics Market is projected to grow from USD 59 million in 2024 to USD 6,848 million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which offers non-invasive options for disease diagnosis, prognosis, and treatment response monitoring across various health conditions....
Lipid Nanoparticles Market to Reach USD 350.5M by 2029
The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projected to rise from USD 135.5 million in 2024 to USD 238.1 million by 2029 at a CAGR of 11.9%. Growth is driven by advancements in LNP-based pharmaceuticals, particularly in anti-cancer and mRNA therapies, though regulatory...
Live Cell Imaging Market worth $4.3 billion by 2028
The global live cell imaging market in terms of revenue was estimated to be worth $2.7 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 10.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders,...